Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 338 followers

Latest posts

Last updated about 18 hours ago

Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’

about 18 hours ago

Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing its first...

‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listing

1 day ago

Elon Musk's SpaceX may be igniting global headlines with the company's astronomical...

Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones

2 days ago

Christelle Huguet, Ph.D., Ipsen’s executive vice president and head of R&D, sits...

Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug

2 days ago

Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after...

Chutes & Ladders—Perrigo CEO ousted over ‘personal conduct’

2 days ago

Over-the-counter drugmaker Perrigo Company is washing its hands of chief executive Patrick...

Novartis' phase 1/2 win tees up regulatory talks about dystrophy drug from $12B Avidity takeover

2 days ago

Novartis has reported a phase 1/2 win for one of the jewels...

‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff

2 days ago

Staring down a $6 billion patent cliff for its prostate cancer drug...

Roche nabs EU approval on label expansions for companion dx platform

3 days ago

Roche received approval through the EU’s In Vitro diagnostic regulation for several...

Genentech executes another round of layoffs, with 3 VPs axed

3 days ago

Genentech vice presidents Vishva Dixit, Man-Wah Tan and Todd McDevitt are among...

Redefining what success looks like in PSC: The evolution of clinical trial endpoints

3 days ago

As understanding of rare cholestatic liver diseases has evolved, endpoint science and...

Novo reports data breach, tells clinical trial patients to 'remain vigilant'

3 days ago

As cybersecurity threats have proliferated across industries in recent years, biopharma companies...